Cargando…

Plasma insulin-like growth factor in primary breast cancer patients treated with adjuvant chemotherapy.

Insulin-like growth factor 1 (IGF-1) plasma level was assayed in 60 breast cancer patients undergoing six courses of adjuvant chemotherapy. The only observed variation was a slight decrease (10%) in IGF-1 concentrations, assayed before treatment, between the first and the second courses of chemother...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peyrat, J. P., RÃ©villion, F., Bonneterre, J.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1998
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150068/ https://www.ncbi.nlm.nih.gov/pubmed/9635846

Ejemplares similares

Insulin-like growth factor 1 receptors in human breast tumour: localisation and quantification by histo-autoradiographic analysis.
por: Jammes, H., et al.
Publicado: (1992)

ERCC1 and CYP1B1 polymorphisms as predictors of response to neoadjuvant chemotherapy in estrogen positive breast tumors
por: Dumont, Aurélie, et al.
Publicado: (2015)

Plasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancer
por: Helle, S I, et al.
Publicado: (2001)

Analysis of p16 gene deletion and point mutation in breast carcinoma.
por: Quesnel, B., et al.
Publicado: (1995)

Dose-dense adjuvant chemotherapy for primary breast cancer
por: Fornier, Monica, et al.
Publicado: (2005)

Insulin-like growth factor binding protein-2 alters the sensitivity of breast cancer cells to chemotherapy
por: Foulstone, EJ, et al.
Publicado: (2010)

Similarity of Serum and Plasma Insulin-like Growth Factor Concentrations
por: Houghton, Lauren C, et al.
Publicado: (2015)

Response to adjuvant chemotherapy in primary breast cancer: no correlation with expression of glutathione S-transferases.
por: Peters, W. H., et al.
Publicado: (1993)

Evaluation of insulin-like growth factor-I in postmenopausal women with breast cancer treated with raloxifene
por: da Silva, Benedito B, et al.
Publicado: (2007)

Biomarkers of fatigue related to adjuvant chemotherapy for breast cancer: evaluation of plasma and lymphocyte expression
por: Cruz, Felipe M, et al.
Publicado: (2015)

Marginal effects of glucose, insulin and insulin-like growth factor on chemotherapy response in endothelial and colorectal cancer cells
por: VOLKOVA, EKATERINA, et al.
Publicado: (2014)

Adjuvant Chemotherapy for Breast Cancer in a Patient with Primary Autoimmune Neutropenia
por: Trus, Michael, et al.
Publicado: (2013)

Hypnosis on patients treated with adjuvant chemotherapy for breast cancer: A feasibility study
por: Fabbro, Michel, et al.
Publicado: (2022)

Nasal septum perforation: a side effect of bevacizumab chemotherapy in breast cancer patients
por: Mailliez, A, et al.
Publicado: (2010)

Mecasermin for primary insulin-like growth factor-1 deficiency
Publicado: (2022)

Comparison and validation of ELISA assays for plasma insulin-like growth factor-1 in the horse
por: Baskerville, Courtnay L., et al.
Publicado: (2017)

Adjuvant chemotherapy for early breast cancer.
por: Henderson, I. C.
Publicado: (1990)

Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factor-binding Proteins in Ovarian Cancer
por: Amutha, Periyasamy, et al.
Publicado: (2017)

Adult growth hormone deficiency treatment with a combination of growth hormone and insulin-like growth factor-1 resulting in elevated sustainable insulin-like growth factor-1 and insulin-like growth factor binding protein 3 plasma levels: a case report
por: Braverman, Eric R, et al.
Publicado: (2010)

Serum and seminal plasma insulin-like growth factor-1 in male infertility
por: Lee, Hyo Serk, et al.
Publicado: (2016)

Plasma Biomarkers of Insulin and the Insulin-like Growth Factor Axis, and Risk of Colorectal Adenoma and Serrated Polyp
por: Hang, Dong, et al.
Publicado: (2019)

Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatment groups
por: Björner, Sofie, et al.
Publicado: (2016)

Locally advanced breast cancer treated with neoadjuvant chemotherapy and adjuvant radiotherapy: a retrospective cohort analysis
por: Klein, Jonathan, et al.
Publicado: (2019)

Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experience.
por: Llombart-Cussac, A., et al.
Publicado: (1998)

Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF
por: Poikonen, P, et al.
Publicado: (1999)

The role of the insulin-like growth factor-1 system in breast cancer
por: Christopoulos, Panagiotis F, et al.
Publicado: (2015)

Alternative Therapy and Abnormal Liver Function During Adjuvant Chemotherapy in Breast Cancer Patients
por: Ahn, Jin-Hee, et al.
Publicado: (2004)

Update on Adjuvant Chemotherapy for Early Breast Cancer
por: Rampurwala, Murtuza M, et al.
Publicado: (2014)

Progress in adjuvant chemotherapy for breast cancer: an overview
por: Anampa, Jesus, et al.
Publicado: (2015)

Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor–binding protein 3?
por: Zielinska, Hanna A, et al.
Publicado: (2015)

Insulin-Like Growth Factor Pathway and the Thyroid
por: Smith, Terry J.
Publicado: (2021)

A systemic literature review of neuroimaging studies in women with breast cancer treated with adjuvant chemotherapy
por: Andryszak, Paulina, et al.
Publicado: (2017)

The intestinal microbiome, weight, and metabolic changes in women treated by adjuvant chemotherapy for breast and gynecological malignancies
por: Uzan-Yulzari, Atara, et al.
Publicado: (2020)

Long‐term symptoms of polyneuropathy in breast and colorectal cancer patients treated with and without adjuvant chemotherapy
por: Bennedsgaard, Kristine, et al.
Publicado: (2020)

Effect of chemotherapy and aromatase inhibitors in the adjuvant treatment of breast cancer on glucose and insulin metabolism—A systematic review
por: Buch, Kristian, et al.
Publicado: (2018)

Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with ∼430 000 women
por: Murphy, N., et al.
Publicado: (2020)

Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function
por: Marshman, Emma, et al.
Publicado: (2002)

The Role of Insulin-Like Growth Factors and Insulin-Like Growth Factor–Binding Proteins in the Nervous System
por: Lewitt, Moira S, et al.
Publicado: (2019)

Effects of Transport Duration and Environmental Conditions in Winter or Summer on the Concentrations of Insulin-Like Growth Factors and Insulin-Like Growth Factor-Binding Proteins in the Plasma of Market-Weight Pigs
por: Wirthgen, Elisa, et al.
Publicado: (2018)

Polymorphisms of Insulin-Like Growth Factor 1 Pathway Genes and Breast Cancer Risk
por: Shi, Joy, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_00fcbb9nb6im05gn6bmaif8shp